Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Zhaoqin Wang and Fuxiang Wang.
Zhaoqin Wang
Connection Strength
0.333
Fuxiang Wang
  1. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020 11 19; 71(16):2027-2034.
    View in: PubMed
    Score: 0.057
  2. Laboratory Diagnosis and Monitoring the Viral Shedding of SARS-CoV-2 Infection. Innovation (N Y). 2020 11 25; 1(3):100061.
    View in: PubMed
    Score: 0.057
  3. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020 06; 26(6):1320-1323.
    View in: PubMed
    Score: 0.055
  4. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 04 28; 323(16):1582-1589.
    View in: PubMed
    Score: 0.055
  5. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering (Beijing). 2020 Oct; 6(10):1192-1198.
    View in: PubMed
    Score: 0.055
  6. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020 03; 63(3):364-374.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.